Table 1.
Demographic and neuropsychological data for all participants.
| CC (n = 28) | CN (n = 29) | T | p value | |||
|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | |||
| Age | 49.21 | 8.15 | 49.27 | 8.59 | 0.03 | 0.978 |
| Education (years) | 10.15 | 2.17 | 10.79 | 2.96 | 0.79 | 0.434 |
| GM (ml) | 603.65 | 44.26 | 617.16 | 61.61 | 0.94 | 0.47 |
| MMSE | 25.71 | 1.94 | 29.17 | 0.92 | 8.63 | <0.001 |
| DS | 5.53 | 1.40 | 6.34 | 1.01 | 2.51 | 0.015 |
| VFT | 8.75 | 2.46 | 11.79 | 2.09 | 5.04 | <0.001 |
| Number of chemotherapy cycles (4–13) | 6.00 | 2.03 | — | — | — | — |
Notes: Abbreviations: SD, standard deviation; CN, cognitively normal; CC, breast cancer patients after chemotherapy; GM, gray matter; MMSE, Mini-Mental State Examination; DS, digit span; VFT, verbal fluency test.